Expanded access to phase II clinical trials in oncology: A step toward increasing scientific validity and compassion

被引：0

作者：

Marcee, Alice K. ^{[1
]}

机构：

[1] So Methodist Univ, Dedman Sch Law, Dallas, TX 75275 USA

来源：

FOOD AND DRUG LAW JOURNAL | 2008年 / 63卷 / 02期

关键词：

D O I：

暂无

中图分类号：

TS2 [食品工业];

学科分类号：

0832 ;

摘要：

引用

页码：439 / 457

页数：19

共 50 条

[41] Absolute neutrophil count clinical trial eligibility criteria for pediatric oncology phase I and phase I/II trials by sponsorship [J].

Ruiz, Jenny ;

Kelly, Rebecca K. ;

Aplenc, Richard ;

Laetsch, Theodore W. ;

Seif, Alix E. .

PEDIATRIC BLOOD & CANCER, 2024, 71 (05)

[42] Inequality factors in access to early-phase clinical trials in oncology in France: results of the EGALICAN-2 study [J].

Charton, E. ;

Baldini, C. ;

Fayet, Y. ;

Schultz, E. ;

Auroy, L. ;

Vallier, E. ;

Italiano, A. ;

Robert, M. ;

Coquan, E. ;

Isambert, N. ;

Moreau, P. ;

Touzeau, C. ;

Le Tourneau, C. ;

Ghrieb, Z. ;

Kiladjian, J. J. ;

Delord, J. -P. ;

Roca, C. Gomez ;

Vey, N. ;

Barlesi, F. ;

Lesimple, T. ;

Penel, N. ;

Soria, J. -C. ;

Massard, C. ;

Besle, S. .

ESMO OPEN, 2023, 8 (04)

[43] Patient care and access to clinical trials in gynaecological oncology: global implications of the early phase of the COVID-19 pandemic [J].

Nasser, Sara ;

Fotopoulou, Christina ;

Gueltekin, Murat ;

Dimitrova, Desislava ;

Bilir, Esra ;

Inci, Guelhan ;

Morice, Philippe ;

Mirza, Mansoor Raza ;

Martin, Antonio Gonzalez ;

Berek, Jonathan ;

Sehouli, Jalid .

ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2024, 310 (01) :577-586

[44] Inefficiency of two-stage designs in phase II oncology clinical trials with high proportion of inevaluable patients [J].

Ji, Lingyun ;

Whangbo, Jennifer ;

Levine, John E. ;

Alonzo, Todd A. .

CONTEMPORARY CLINICAL TRIALS, 2022, 120

[45] Design considerations for phase I/II dose finding clinical trials in Immuno-oncology and cell therapy [J].

Liu, Rachael ;

Lin, Jianchang ;

Li, Pin .

CONTEMPORARY CLINICAL TRIALS, 2020, 96

[46] Screening Intervention to Identify Eligible Patients and Improve Accrual to Phase II-IV Oncology Clinical Trials [J].

Chen, Leo ;

Grant, Janice ;

Cheung, Winson Y. ;

Kennecke, Hagen F. .

JOURNAL OF ONCOLOGY PRACTICE, 2013, 9 (04) :E174-E181

[47] Adaptive phase I/II clinical trials for drug combination assessment in oncology using the outcomes of each cycle [J].

Yada, Shinjo ;

Hamada, Chikuma .

PHARMACEUTICAL STATISTICS, 2017, 16 (06) :433-444

[48] ANALYSIS OF PHASE-II CLINICAL-TRIALS IN HEMATOLOGY AND ONCOLOGY - COMPARISON OF THE TRIANGULAR TEST TO THE USUAL METHODS [J].

BENICHOU, J ;

BELLISSANT, E ;

CHASTANG, C .

STATISTICS IN MEDICINE, 1991, 10 (06) :989-990

[49] Differences in Absolute Neutrophil Count Eligibility Criteria of Pediatric Phase I and Phase I/II Oncology Clinical Trials According to Sponsorship [J].

Kelly, Rebecca ;

Ruiz, Jenny ;

Aplenc, Richard ;

Laetsch, Theodore W. ;

Seif, Alix E. .

BLOOD, 2023, 142

[50] Patients in Pediatric Phase I and Early Phase II Clinical Oncology Trials at Gustave Roussy: A 13-Year Center Experience [J].

Bautista, Francisco ;

Di Giannatale, Angela ;

Dias-Gastellier, Nathalie ;

Fahd, Mony ;

Valteau-Couanet, Dominique ;

Couanet, Dominique ;

Grill, Jacques ;

Brugieres, Laurence ;

Dufour, Christelle ;

Gaspar, Nathalie ;

Minard-Colin, Veronique ;

Kalifa, Chantal ;

Oberlin, Odile ;

Patte, Catherine ;

Vassal, Gilles ;

Geoerger, Birgit .

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2015, 37 (02) :E102-E110

← 1 2 3 4 5 →